EpiBiologics is a clinical-stage biotechnology company based in San Mateo, California, developing bispecific antibodies for directed extracellular protein degradation. Its proprietary EpiTAC platform leverages an atlas of 270+ degradation-inducing cell-surface receptors to build tissue-selective therapies that degrade disease-causing proteins… - View it on GitHub